We can't find the internet
Attempting to reconnect
26689.1 PFLS-LS
26689.1 PFLS-LS
Résumé
Development of an ideal drug engine to provide biologics with an inherent low immunogenicity risk
Textes supplémentaires
Abstract
We envision an ideal drug engine based on a human protein providing novel biologics to address unmet medical needs by merging the low immunogenicity risk of human antibodies and the excellent versatility, efficient developability and intellectual property benefits of an alternative scaffold.
Participants
Andreas Plückthun
Kontaktperson
plueckthun@bioc.uzh.ch
Universität Zürich Department of Biochemistry Andreas Plückthun Winterthurerstrasse 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2017-08-31
- Date de fin
- 2019-02-28
- Coûts totaux approuvés
- CHF 596882.25
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%